Trump Administration Drives Access to More High-Quality Medicare Plan Choices in 2020
Newsroom Press Release
Trump Administration Drives Down Drug Costs for Seniors
Today, the Centers for Medicare & Medicaid Services (CMS), under the leadership of President Trump, announced that, for the third year in a row, the average basic premium for Medicare Part D prescription drug plans, which cover prescription drugs that beneficiaries pick up at a pharmacy, is projected to decline.
Newsroom Press ReleaseClaim Rejection and Denials for Providers on the Preclusion List to begin on April 1, 2019
Newsroom Fact Sheet
CMS Updates Drug Dashboards with Prescription Drug Pricing and Spending Data
This Administration’s version of the drug dashboards adds information on the manufacturers that are responsible for price increases and includes pricing and spending data for thousands more drugs across Medicare Parts B and D and Medicaid.
Newsroom Press ReleaseOpioid Prescribing Mapping Tool Improved with Medicaid and Rural Data
New features offer local communities greater transparency into opioid prescribing rates.
Newsroom Press ReleaseCMS Announces New Model to Lower Drug Prices in Medicare Part D and Transformative Updates to Existing Model for Medicare Advantage
Newsroom Press Release
Contract Year (CY) 2020 Medicare Advantage and Part D Drug Pricing Proposed Rule (CMS-4180-P)
CMS is committed to implementing President Trump’s blueprint to lower drug costs and reduce out-of-pocket costs for patients. In line with the policies discussed in the President’s blueprint, CMS issued a proposed rule on November 26, 2018 that solicits public comments on potential policies that would remove administrative hurdles to offer lower cost options to seniors and provide support for private sector partners by providing them the tools to lower the cost of prescription drugs.
Newsroom Fact SheetCMS Takes Action to Lower Prescription Drug Costs by Modernizing Medicare
Today, the Centers for Medicare & Medicaid Services (CMS) proposed polices for 2020 to strengthen and modernize the Medicare Part C and D programs. The proposal would ensure that Medicare Advantage and Part D plans have more tools to negotiate lower drug prices, and the agency is also considering a policy that would require pharmacy rebates to be passed on to seniors to lower their drug costs at the pharmacy counter.
Newsroom Press ReleaseCMS Proposes to Require Manufacturers to Disclose Drug Prices in Television Ads
Proposed rule would further the Trump Administration’s commitment to lower prescription drug prices by requiring companies to list prices for prescription drugs covered in Medicare or Medicaid.
Newsroom Press ReleaseSpeech: Remarks by Administrator Seema Verma at the Financial Times Pharma Pricing and Value Summit
Remarks by Administrator Seema Verma at the Financial Times Pharma Pricing and Value Summit (As prepared for delivery – September 13, 2018)
Newsroom Press Release